Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis

Prostaglandin E synthase (PGES) including isoenzymes of membrane-associated PGES (mPGES)-1, mPGES-2, and cytosolic PGES (cPGES) is the recently identified terminal enzyme of the arachidonic acid cascade. PGES converts prostaglandin (PG)H2 to PGE2 downstream of cyclooxygenase (COX). We investigated the expression of PGES isoenzyme in articular chondrocytes from patients with osteoarthritis (OA). Chondrocytes were treated with various cytokines and the expression of PGES isoenzyme mRNA was analyzed by the reverse transcription–polymerase chain reaction and Northern blotting, whereas Western blotting was performed for protein expression. The subcellular localization of mPGES-1 was determined by immunofluorescent microscopy. Conversion of arachidonic acid or PGH2 to PGE2 was measured by enzyme-linked immunosorbent assay. Finally, the expression of mPGES-1 protein in OA articular cartilage was assessed by immunohistochemistry. Expression of mPGES-1 mRNA in chondrocytes was significantly induced by interleukin (IL)-1β or tumor necrosis factor (TNF)-α, whereas other cytokines, such as IL-4, IL-6, IL-8, IL-10, and interferon-γ, had no effect. COX-2 was also induced under the same conditions, although its pattern of expression was different. Expression of cPGES, mPGES-2, and COX-1 mRNA was not affected by IL-1β or TNF-α. The subcellular localization of mPGES-1 and COX-2 almost overlapped in the perinuclear region. In comparison with 6-keto-PGF1α and thromboxane B2, the production of PGE2 was greater after chondrocytes were stimulated by IL-1β or TNF-α. Conversion of PGH2 to PGE2 (PGES activity) was significantly increased in the lysate from IL-1β-stimulated chondrocytes and it was inhibited by MK-886, which has an inhibitory effect on mPGES-1 activity. Chondrocytes in articular cartilage from patients with OA showed positive immunostaining for mPGES-1. These results suggest that mPGES-1 might be important in the pathogenesis of OA. It might also be a potential new target for therapeutic strategies that specifically modulate PGE2 synthesis in patients with OA.

[1]  B. Samuelsson,et al.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[3]  Leslie J. Crofford,et al.  Primer on the Rheumatic Diseases , 1999 .

[4]  M. Sakata,et al.  The role of C-C chemokines and their receptors in osteoarthritis. , 2001, Arthritis and rheumatism.

[5]  Makoto Murakami,et al.  Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis* , 2000, The Journal of Biological Chemistry.

[6]  Yves Bureau,et al.  Microsomal Prostaglandin E Synthase-1 Is a Major Terminal Synthase That Is Selectively Up-Regulated During Cyclooxygenase-2-Dependent Prostaglandin E2 Production in the Rat Adjuvant-Induced Arthritis Model , 2003, The Journal of Immunology.

[7]  L. Crofford,et al.  Microsomal Prostaglandin E Synthase Is Regulated by Proinflammatory Cytokines and Glucocorticoids in Primary Rheumatoid Synovial Cells1 , 2001, The Journal of Immunology.

[8]  S. Abramson,et al.  The role of nitric oxide in articular cartilage breakdown in osteoarthritis. , 1998, Current opinion in rheumatology.

[9]  P. Robbins,et al.  Nitric oxide in osteoarthritis. , 1999, Osteoarthritis and cartilage.

[10]  F. Berenbaum,et al.  Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase. , 2002, The Biochemical journal.

[11]  L. Bonassar,et al.  Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. , 1997, Osteoarthritis and cartilage.

[12]  J. Sieper,et al.  Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. , 1999, The Journal of rheumatology.

[13]  J. Pelletier,et al.  The Induction of Cell Death in Human Osteoarthritis Chondrocytes by Nitric Oxide Is Related to the Production of Prostaglandin E2 Via the Induction of Cyclooxygenase-2 , 2000, The Journal of Immunology.

[14]  M. Beppu,et al.  Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. , 2003, Arthritis and rheumatism.

[15]  Makoto Murakami,et al.  Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[16]  L. Crofford,et al.  Critical role of C/EBPδ and C/EBPβ factors in the stimulation of the cyclooxygenase‐2 gene transcription by interleukin‐1β in articular chondrocytes , 2000 .

[17]  M. Murakami,et al.  Diverse functional coupling of prostanoid biosynthetic enzymes in various cell types. , 1999, Advances in experimental medicine and biology.

[18]  R. Erikson,et al.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Smith,et al.  Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. , 1997, The Journal of rheumatology.

[20]  J. Pelletier,et al.  Cytokines and their role in the pathophysiology of osteoarthritis. , 1999, Frontiers in bioscience : a journal and virtual library.

[21]  M. Shingu,et al.  Effects of recombinant human IL-Iβ on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes , 1991, Inflammation.

[22]  M. Aihara,et al.  Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblasts. , 1997, Biochemical pharmacology.

[23]  Seiji Ito,et al.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. , 2002, Biochemical and biophysical research communications.

[24]  J. Pelletier,et al.  Cytokines and inflammation in cartilage degradation. , 1993, Rheumatic diseases clinics of North America.

[25]  R. Borzì,et al.  Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. , 1998, Arthritis and rheumatism.

[26]  D. Woolley,et al.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. , 2001, Arthritis and rheumatism.

[27]  M. Veronesi,et al.  Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis. , 1996, Bollettino della Societa italiana di biologia sperimentale.

[28]  J. Lapointe,et al.  Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Elson,et al.  Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints. , 2002, Osteoarthritis and cartilage.

[30]  G. Freeman,et al.  Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  X. Chevalier.  Upregulation of enzymatic activity by interleukin-1 in osteoarthritis. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  V Vécsei,et al.  Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. , 2002, Osteoarthritis and cartilage.

[33]  J. Pelletier,et al.  The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.

[34]  T. Kikuchi,et al.  Production of cytokines by chondrocytes and its role in proteoglycan degradation. , 1991, The Journal of rheumatology. Supplement.

[35]  M. Currie,et al.  Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. , 2002, Arthritis and rheumatism.

[36]  L. Crofford,et al.  Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes. , 2000, European journal of biochemistry.

[37]  B. Varnum,et al.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.

[38]  J. Pelletier,et al.  The role of cytokines in osteoarthritis pathophysiology. , 2002, Biorheology.

[39]  R. Dixon,et al.  Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. , 1990, The Journal of biological chemistry.

[40]  T. Koshino,et al.  Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. , 2002, The Journal of rheumatology.

[41]  D. Riendeau,et al.  Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis* , 2001, The Journal of Biological Chemistry.

[42]  G. R. Dodge,et al.  Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. , 1989, The Journal of clinical investigation.

[43]  M. Murakami,et al.  Transcriptional Regulation of the Membrane-associated Prostaglandin E2 Synthase Gene , 2002, The Journal of Biological Chemistry.

[44]  F. Berenbaum,et al.  Cyclooxygenase activity in chondrocytes from osteoarthritic and healthy cartilage. , 1999, Revue du rhumatisme.

[45]  Y. Urade,et al.  Prostaglandin D, E, and F synthases. , 1995, Journal of lipid mediators and cell signalling.

[46]  M. Murakami,et al.  Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. , 1997, Biochemical and biophysical research communications.

[47]  J. Pelletier,et al.  Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[48]  T. Koshino,et al.  Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. , 1998, European journal of pharmacology.